Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

  • Nov 2024
Endocrine Society to host virtual Science Writers Conference Nov. 14

Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications.

Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14.

What: The Virtual Science Writers Conference will examine:

  • Rising demand for anti-obesity medications, including semaglutide and tirzepatide
  • An FDA alert regarding the risk of dosing errors associated with compounded versions of these medications
  • Strategies to navigate supply issues

Who:

  • Caroline Apovian, MD, FACP, of Boston University Chobanian & Avedisian School of Medicine in Boston, Mass.
  • Maria Daniela Hurtado Andrade, MD, PhD, of the Mayo Clinic in Jacksonville, Fla.

When: Thursday, Nov. 14 at 10 AM Eastern

Register to attend the virtual Science Writers Conference by emailing [email protected]. Registered reporters will receive log-in details.

Priority will be given to journalists seeking to register. The recording of this event will be made available on the Society’s YouTube channel for other audiences.

Find more in